Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last C$0.88 CAD
Change Today +0.03 / 3.53%
Volume 19.3K
IMV On Other Exchanges
Symbol
Exchange
Toronto
OTC US
Frankfurt
As of 12:26 PM 09/2/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Randal D. Chase Ph.D.

AgeTotal Calculated CompensationThis person is connected to 53 board members in 6 different organizations across 10 different industries.

See Board Relationships
65--

Background*

Dr. Randal D. Chase, Ph.D., served as the Chief Executive Officer and President of ImmunoVaccine Technologies Inc. from 2006 to April 14, 2011 and also served as its Acting Chief Financial Officer. Dr. Chase served as the President of Global Mandate of Shire Biologics, a division of Shire Pharmaceuticals Plc from May 2001 to 2004. Dr. Chase held senior positions at several pharmaceutical and biotechnology companies, including a number of leading vaccine companies. He ...

Read Full Background

Corporate Headquarters*

1344 Summer Street
Halifax, Nova Scotia B3H 0A8

Canada

Phone: 902-492-1819
Fax: 902-492-0888

Board Members Memberships*

Director
2004-Present
Independent Non Executive Director, Member of Nominations Committee, Member of Audit Committee and Member of Remuneration Committee
2004-Present
Chairman and Member of Audit Committee
2014-Present
Chairman of the Board
2015-Present
Independent Director, Chairman of Compensation Committee and Member of Audit Committee
2015-Present
Director

Education*

PhD
University Of British Columbia
BS 1974
Bishop's University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IMV:CN C$0.88 CAD +0.03

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IMMUNOVACCINE INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.